Rani Therapeutics (RANI) Stock: Why It's Up Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $0.65, +1.45% vs the prior close of $0.64.
- Volume 455.85K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
RANI rises 1.5% to $0.65. Closed at $0.65, +1.45% vs the prior close of $0.64. Day range $0.63–$0.66, opened at $0.64.
RANI daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — RANI rises 1.5% to $0.65
- Closed at $0.65, +1.45% vs the prior close of $0.64. Day range $0.63–$0.66, opened at $0.64.
- Volume was 455.85K shares, 0.8x its 50-day average of 603.18K.
- Price is -19.3% vs its 50-day average ($0.81) and -32.8% vs its 200-day average ($0.97).
- 52-week range $0.61–$3.87; today's close sits at 1% of that range, 83.2% below the 52-week high.
Oct 16, 2026 — RANI slides 5.8% to $0.64, a 3-month low
- Closed at $0.64, -5.79% vs the prior close of $0.68. Day range $0.63–$0.70, opened at $0.69.
- Volume was 589.11K shares, 1.0x its 50-day average of 605.32K.
- Price is -20.8% vs its 50-day average ($0.81) and -34.1% vs its 200-day average ($0.97).
- 52-week range $0.46–$3.87; today's close sits at 5% of that range, 83.4% below the 52-week high.
Oct 15, 2026 — RANI rises 1.5% to $0.68
- Closed at $0.68, +1.49% vs the prior close of $0.67. Day range $0.65–$0.69, opened at $0.67.
- Volume was 450.20K shares, 0.7x its 50-day average of 611.26K.
- Price is -16.2% vs its 50-day average ($0.81) and -30.3% vs its 200-day average ($0.98).
- 52-week range $0.46–$3.87; today's close sits at 6% of that range, 82.4% below the 52-week high.
Oct 14, 2026 — RANI slides 8.6% to $0.67, a 1-month low on 2.0x normal volume
- Closed at $0.67, -8.59% vs the prior close of $0.73. Day range $0.67–$0.75, opened at $0.71.
- Volume was 1.20M shares, 2.0x its 50-day average of 609.74K — unusually heavy trading.
- Price is -17.6% vs its 50-day average ($0.81) and -31.6% vs its 200-day average ($0.98).
- 52-week range $0.46–$3.87; today's close sits at 6% of that range, 82.7% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — RANI dips 2.4% to $0.73, a 1-month low
- Closed at $0.73, -2.40% vs the prior close of $0.75. Day range $0.71–$0.77, opened at $0.75.
- Volume was 918.70K shares, 1.5x its 50-day average of 603.73K.
- Price is -10.2% vs its 50-day average ($0.82) and -25.4% vs its 200-day average ($0.98).
- 52-week range $0.44–$3.87; today's close sits at 8% of that range, 81.1% below the 52-week high.
Oct 12, 2026 — RANI slides 6.0% to $0.75
- Closed at $0.75, -6.01% vs the prior close of $0.80. Day range $0.75–$0.80, opened at $0.79.
- Volume was 431.00K shares, 0.7x its 50-day average of 603.84K.
- Price is -8.1% vs its 50-day average ($0.82) and -23.9% vs its 200-day average ($0.99).
- 52-week range $0.44–$3.87; today's close sits at 9% of that range, 80.6% below the 52-week high.
Oct 9, 2026 — RANI rises 0.9% to $0.80
- Closed at $0.80, +0.88% vs the prior close of $0.79. Day range $0.79–$0.82, opened at $0.80.
- Volume was 235.50K shares, 0.4x its 50-day average of 603.79K — lighter than usual.
- Price is -2.3% vs its 50-day average ($0.82) and -19.3% vs its 200-day average ($0.99).
- 52-week range $0.44–$3.87; today's close sits at 10% of that range, 79.4% below the 52-week high.
Oct 8, 2026 — RANI dips 2.5% to $0.79
- Closed at $0.79, -2.46% vs the prior close of $0.81. Day range $0.79–$0.84, opened at $0.80.
- Volume was 451.30K shares, 0.7x its 50-day average of 609.22K.
- Price is -3.2% vs its 50-day average ($0.82) and -20.3% vs its 200-day average ($0.99).
- 52-week range $0.44–$3.87; today's close sits at 10% of that range, 79.5% below the 52-week high.
Oct 7, 2026 — RANI dips 2.1% to $0.81
- Closed at $0.81, -2.05% vs the prior close of $0.83. Day range $0.79–$0.84, opened at $0.81.
- Volume was 232.20K shares, 0.4x its 50-day average of 611.40K — lighter than usual.
- Price is -0.9% vs its 50-day average ($0.82) and -18.6% vs its 200-day average ($1.00).
- 52-week range $0.44–$3.87; today's close sits at 11% of that range, 79.0% below the 52-week high.
Oct 6, 2026 — RANI jumps 7.0% to $0.83
- Closed at $0.83, +6.97% vs the prior close of $0.77. Day range $0.78–$0.83, opened at $0.80.
- Volume was 954.30K shares, 1.6x its 50-day average of 609.07K.
- Price is +1.1% vs its 50-day average ($0.82) and -17.1% vs its 200-day average ($1.00).
- 52-week range $0.44–$3.87; today's close sits at 11% of that range, 78.6% below the 52-week high.
Oct 5, 2026 — RANI slides 4.4% to $0.77
- Closed at $0.77, -4.44% vs the prior close of $0.81. Day range $0.77–$0.84, opened at $0.84.
- Volume was 582.00K shares, 0.9x its 50-day average of 626.30K.
- Price is -5.4% vs its 50-day average ($0.82) and -22.8% vs its 200-day average ($1.00).
- 52-week range $0.44–$3.87; today's close sits at 10% of that range, 80.0% below the 52-week high.
Oct 2, 2026 — RANI rises 1.9% to $0.81
- Closed at $0.81, +1.88% vs the prior close of $0.80. Day range $0.80–$0.83, opened at $0.81.
- Volume was 418.30K shares, 0.6x its 50-day average of 646.63K.
- Price is -1.2% vs its 50-day average ($0.82) and -19.4% vs its 200-day average ($1.01).
- 52-week range $0.44–$3.87; today's close sits at 11% of that range, 79.0% below the 52-week high.
RANI bull case vs bear case (from the data)
- Annual revenue grew 58.9% in the latest fiscal year (SEC XBRL).
- Insiders made 12 open-market purchases in the last 12 months.
- Price is -19.3% vs its 50-day average — short-term trend is down.
- Price is -32.8% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $29.67M.
- Insider selling outweighs buying: 13 sales vs 12 open-market buys among the 25 most recent reported insider trades (Form 4, last 12 months).
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
RANI latest news & SEC filings
Every SEC filing by or about RANI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Imran Talat had withheld for taxes 7,928 shares at $0.76 (≈$6.02K) on Sep 27, 2026; now holds 461,808
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Javadi Alireza had withheld for taxes 309 shares at $0.76 (≈$235) on Sep 27, 2026; now holds 9,071
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $1.71M (prior year $0)
- Net income: -$7.39M (prior year -$6.69M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.04 (prior year -$0.18) (loss narrowed vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 4, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Jul 31, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 23, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Imran Mir A bought 36,000 shares at $0.69 (≈$24.84K) on Jul 21, 2026
- Imran Mir A bought 36,000 shares at $0.69 (≈$24.84K) on Jul 21, 2026
- Imran Mir A bought 36,000 shares at $0.69 (≈$24.84K) on Jul 21, 2026
- Imran Mir A bought 36,000 shares at $0.69 (≈$24.84K) on Jul 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Javadi Alireza sold 386 shares at $0.78 (≈$301) on Mar 27, 2026
- Javadi Alireza sold 386 shares at $0.78 (≈$301) on Mar 27, 2026
- Javadi Alireza sold 386 shares at $0.78 (≈$301) on Mar 27, 2026
- Javadi Alireza sold 386 shares at $0.78 (≈$301) on Mar 27, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jul 15, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Jun 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Things to know before you trade RANI
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 15, 2026, Mar 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.90% (largest 8.6%).
- Liquidity: about 559.34K shares (≈$363.74K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.65 vs a range of $0.61–$3.87 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 12 open-market buys, 13 sales; latest: Mir A Imran bought 36,000 shares on Jul 21, 2026.
- Latest filings: 10-Q Aug 13, 2026; 8-K Aug 13, 2026; 8-K Aug 4, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
RANI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 0.64 | 0.66 | 0.63 | 0.65 | 455.85K |
| Oct 16, 2026 | 0.69 | 0.70 | 0.63 | 0.64 | 589.20K |
| Oct 15, 2026 | 0.67 | 0.69 | 0.65 | 0.68 | 450.20K |
| Oct 14, 2026 | 0.71 | 0.75 | 0.67 | 0.67 | 1.20M |
| Oct 13, 2026 | 0.75 | 0.77 | 0.71 | 0.73 | 918.70K |
| Oct 12, 2026 | 0.79 | 0.80 | 0.75 | 0.75 | 431.00K |
| Oct 9, 2026 | 0.80 | 0.82 | 0.79 | 0.80 | 235.50K |
| Oct 8, 2026 | 0.80 | 0.84 | 0.79 | 0.79 | 451.30K |
| Oct 7, 2026 | 0.81 | 0.84 | 0.79 | 0.81 | 232.20K |
| Oct 6, 2026 | 0.80 | 0.83 | 0.78 | 0.83 | 954.30K |
| Oct 5, 2026 | 0.84 | 0.84 | 0.77 | 0.77 | 582.00K |
| Oct 2, 2026 | 0.81 | 0.83 | 0.80 | 0.81 | 418.30K |
| Oct 1, 2026 | 0.82 | 0.85 | 0.79 | 0.80 | 484.00K |
| Sep 30, 2026 | 0.81 | 0.82 | 0.78 | 0.79 | 468.20K |
| Sep 29, 2026 | 0.80 | 0.82 | 0.78 | 0.80 | 405.60K |
| Sep 28, 2026 | 0.76 | 0.80 | 0.74 | 0.78 | 624.60K |
| Sep 25, 2026 | 0.75 | 0.77 | 0.73 | 0.76 | 382.60K |
| Sep 24, 2026 | 0.78 | 0.79 | 0.75 | 0.75 | 607.00K |
| Sep 23, 2026 | 0.81 | 0.81 | 0.77 | 0.77 | 648.60K |
| Sep 22, 2026 | 0.80 | 0.83 | 0.77 | 0.78 | 651.60K |
About Rani Therapeutics
Rani Therapeutics (RANI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN JOSE, CA. State of incorporation: CA. Fiscal year ends December 31. SEC CIK 1856725.
RANI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dennis A Ausiello | Director | Jun 1, 2026 |
| Jean Luc Butel | Director | Jun 1, 2026 |
| Vasudev Jaiprakash Bailey | Director | Jun 1, 2026 |
| Abraham Bassan | Director | Jun 1, 2026 |
| Michelle Gilson | Director | Aug 4, 2026 |
| Mir A Imran | Director | Jul 23, 2026 |
| Talat Imran | Chief Executive Officer | Sep 29, 2026 |
| Lisa Ann Rometty | Director | Jun 1, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Talat Imran | Chief Executive Officer | Sep 29, 2026 |
| Alireza Javadi | Chief Technical Officer | Sep 29, 2026 |
| Nicholas Maestas | Chief Financial Officer | Jul 21, 2026 |
| Kate Mckinley | Chief Business Officer | Jun 5, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 21, 2026 | Mir A Imran | Buy | 36,000 | $0.69 |
| Jul 21, 2026 | Mir A Imran | Buy | 36,000 | $0.69 |
| Jul 21, 2026 | Mir A Imran | Buy | 36,000 | $0.69 |
| Jul 21, 2026 | Mir A Imran | Buy | 36,000 | $0.69 |
| Jul 17, 2026 | Talat Imran | Buy | 35,000 | $0.72 |
| Jul 17, 2026 | Talat Imran | Buy | 35,000 | $0.72 |
| Jul 17, 2026 | Talat Imran | Buy | 35,000 | $0.72 |
| Jul 17, 2026 | Talat Imran | Buy | 35,000 | $0.72 |
| Mar 27, 2026 | Alireza Javadi | Sale | 386 | $0.78 |
| Mar 27, 2026 | Alireza Javadi | Sale | 386 | $0.78 |
| Mar 27, 2026 | Alireza Javadi | Sale | 386 | $0.78 |
| Mar 27, 2026 | Alireza Javadi | Sale | 386 | $0.78 |
| Oct 23, 2025 | Mir A Imran | Buy | 2,083,334 | $0.61 |
| Oct 23, 2025 | Mir A Imran | Buy | 2,083,334 | $0.61 |
| Oct 23, 2025 | Mir A Imran | Buy | 2,083,334 | $0.61 |
RANI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.63M | $-29.67M | -0.45 | $-18.71M |
| Dec 31, 2024 | $1.03M | $-30.02M | -1.05 | $-35.50M |
| Dec 31, 2023 | $0 | $-33.97M | -1.33 | $-51.24M |
| Dec 31, 2022 | $0 | $-30.59M | -1.28 | $-46.52M |
| Dec 31, 2021 | $2.72M | $-8.33M | -0.43 | $-32.24M |
Latest balance sheet: total assets $60.84M, total liabilities $12.86M, cash $4.87M (as of Jun 30, 2026).
RANI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $0.80 |
| May 15, 2026 | 8-K Item 2.02 (results) | $1.08 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $1.08 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.27 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $0.53 |
| May 13, 2025 | 8-K Item 2.02 (results) | $0.48 |
| Mar 31, 2025 | 8-K Item 2.02 (results) | $1.26 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $2.35 |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Mar 20, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on RANI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.